Indian generic pharma and global regulatory challenges
Dr Gopakumar G Nair, Chief Executive Officer, Gopakumar Nair Associates talks about why the regulatory scenario in the domestic…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharma marketing In need of a reboot
Will China’s recent crackdown on the pharmaceutical industry’s unethical marketing practices result in any long lasting changes?…
Code of conduct: A pill to cure corrup
Unethical means of promotion employed by pharma firms have underlined the importance of a Uniform Code of Pharmaceutical Marketing…
Adopting new avenues
Pharma marketing is undergoing a metamorphosis, aided by digital technology which has not only opened up new vistas for brand…
‘Quality is a philosophy regardless of geographies’
Dr Alexandra Pearce, Senior Vice President and Head Global Regulatory Affairs - Glenmark Pharmaceuticals, talks about the…
Merck Serono partners with Sutro Biopharma
Merck Serono and Sutro Biopharma, San Francisco, a bio-pharmaceutical company developing antibody drug conjugates and bispecific…
Silver Leaf Oak acquires stake in Syngene International
The stake will be acquired from BRL at a valuation of Rs 3800 crores
AstraZeneca ties up with Lilly
Announces alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer’s disease
Indian pharma could gain from China-India MoUs
MoUs aimed at facilitating market access, cooperation on drug regulations could increase inroads into China pharma market